Regina Jakacki, MD; Nicolette Luery, PharmD; Patrick McVerry, PhD; Beverly Lange, MD
Patients with Hodgkin disease are at risk for life-threatening Haemophilus influenzae infections (1, 2). Splenectomy interferes with opsonization and phagocytosis of encapsulated bacteria (3), and chemotherapy and irradiation impair serologic response to polysaccharide antigen (2, 4, 5). Response to protein antigen remains relatively intact (6). The H. influenzae polyribose polysaccharide diphtheria protein-conjugate vaccine has been used to overcome the inability of infants to respond to polysaccharide antigen (7, 8). To determine whether splenectomized patients with Hodgkin disease could also respond we immunized 23 patients with conjugate vaccine.
Twenty-three patients with Hodgkin disease, 6 to 20 years old
Learn more about subscription options.
Register Now for a free account.
Jakacki R, Luery N, McVerry P, Lange B. Haemophilus influenzae Diphtheria Protein Conjugate Immunization after Therapy in Splenectomized Patients with Hodgkin Disease. Ann Intern Med. 1990;112:143–144. doi: 10.7326/0003-4819-112-2-143
Download citation file:
Published: Ann Intern Med. 1990;112(2):143-144.
Infectious Disease, Prevention/Screening.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only